KRC-108
KRC-108 is a multi-kinase inhibitor targeting Ron, Flt3, TrkA, and c-Met, with enhanced activity against oncogenic c-Met mutants. It demonstrates potent anti-proliferative effects in vitro (GI50 0.01-4.22 μM) and inhibits tumor growth in HT29 and NCI-H441 xenograft models, supporting its role as a lead compound in oncology research.
Product Specifications
CAS Number
1146944-35-5
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Smiles
NC1=C (C2=NC=3C (O2) =CC=CC3) C=C (C=N1) C4=CN (N=C4) C5CCNCC5
Molecular Formula
C20H20N6O
Molecular Weight
360.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4165003 1.0 µg DNA
Zar1 sgRNA CRISPR Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details 